Showing results (501-510 of 532) with videos related to
Sort By:
Pageof 54
Patterns (New York, N.Y.)|November 16, 2020
KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 ResponseJustin T Reese, Deepak Unni, Tiffany J Callahan, et al.Cold Spring Harbor Molecular Case Studies|April 3, 2021
A description of novel variants and review of phenotypic spectrum in UBA5-related early epileptic encephalopathyLauren C Briere, Melissa A Walker, Frances A High, et al.EGEMS (Washington, DC)|October 8, 2016
A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record DataMichael G Kahn, Tiffany J Callahan, Juliana Barnard, et al.Journal of Neurochemistry|August 4, 2004
Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid depositsJun Yao, Suzana S Petanceska, Thomas J Montine, et al.Vaccine|April 3, 2017
Semiconductor diode laser device adjuvanting intradermal vaccineYoshifumi Kimizuka, John J Callahan, Zilong Huang, et al.Medrxiv : the Preprint Server for Health Sciences|April 28, 2021
NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort studyJustin T Reese, Ben Coleman, Lauren Chan, et al.Chest|March 8, 2022
Pulmonary and Critical Care Considerations for e-Cigarette, or Vaping, Product Use-Associated Lung InjuryDon Hayes, Amy Board, Carolyn S Calfee, et al.Journal of Medicinal Chemistry|July 3, 1998
Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonistH Tecle, S D Barrett, D J Lauffer, et al.Molecular Therapy. Nucleic Acids|April 21, 2025
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe diseaseRyan A Oliver, Meghan E Ahern, Perla G Castaneda, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2019
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNAL Tan, S Sandhu, R J Lee, et al.Pageof 54